Para-phenylenediamine (PPD) is a widely used ingredient in hair dyes and black henna. Rarely, long-term use of topical PPD-containing products can lead to systemic absorption and toxicity, including chronic renal failure. We describe the first reported case of reversible acute hepatitis related to PPD-containing hair dye shampoo. Given the widespread availability of PPD-containing consumer products, it is important for family physicians to be aware of this risk, particularly as many products are advertised as being “all-natural” or “organic.” When assessing patients with elevated liver enzyme levels, it is crucial to obtain a complete history, including use of hair-darkening shampoos or henna applications, to allow timely diagnosis and management.
Case
A 63-year-old White male patient was referred to an ambulatory hepatology clinic with elevated liver enzyme levels (alanine aminotransferase [ALT]=214 U/L, aspartate aminotransferase [AST]=166 U/L, and a normal alkaline phosphatase [ALP] level) noted on routine laboratory monitoring results in January 2018 (Figure 1). He was otherwise asymptomatic and all other laboratory test results were normal. His medical history included HIV infection suppressed with darunavir, ritonavir, etravirine, raltegravir, maraviroc, emtricitabine, and tenofovir alafenamide, with a CD4 lymphocyte count of more than 500 cells/mm3, rosuvastatin and ezetimibe for dyslipidemia, and citalopram for depression. His medication doses had been stable for several years, with no new over-the-counter products or herbal remedies. His antiretroviral treatment history had included didanosine and stavudine in the distant past (10 to 20 years previously), but his liver enzyme levels had been normal then. He was immune to hepatitis A and B viruses, had negative test results for hepatitis C and E viruses, and had past exposure to Epstein-Barr virus, cytomegalovirus, and varicella-zoster virus. The patient had no prior history of liver disease or cirrhosis, with normal ALT (44 U/L) and AST (30 U/L) levels in September 2017. He abstained from alcohol, tobacco, and recreational drug use. The patient did not have other risk factors for viral hepatitis or fatty liver. Iron overload was deemed unlikely based on his racial background.
Ultrasound findings showed nothing suggestive of biliary liver disease. Liver biopsy findings showed 50% to 60% fat with features of steatohepatitis and moderately severe fibrosis without cirrhosis. His liver enzyme levels continued to rise, peaking in March 2018 with an ALT level of 325 U/L and an AST level of 241 U/L. In May 2018 the patient mentioned that he had started using a new shampoo in December 2017 to darken his hair. Despite experiencing a severe skin reaction on his legs and left forearm, he had not initially reported this to his physician and had continued to use the shampoo in place of his regular shampoo. After the hair-darkening shampoo was discovered to contain PPD, he was advised to discontinue the product and his ALT and AST levels dropped by 3-fold in 2 months. According to the Roussel Uclaf Causality Assessment Method,1 a structured assessment instrument widely used to assess the cause of drug-induced liver injury,2 his hepatitis was probably due to the PPD-containing shampoo.
Discussion
Para-phenylenediamine is an aromatic amine derived from alanine and is an ingredient of kala pathar (black stone in Urdu), which is a component of some hair dyes. Para-phenylenediamine is a crystalline solid that is present as white lumps or flakes that darken upon exposure to air. Para-phenylenediamine is readily available for bulk purchase online and is widely used in hair dyes, black henna, fur dyes, plastic, photographic products, and printer inks.3 In developed countries, hair dye products contain a maximum of 2% PPD, but in developing countries, concentrations can range from 2% to 90% due to lack of standard regulations.4 In the United States, PPD was found to be present in 78% of 107 hair dyes from 10 major brands, of which 9% were marketed to men for use on facial hair.5
Para-phenylenediamine is converted to its active metabolite, benzoquinone diamine, by the cytochrome P450 system. Oxidation of this active metabolite leads to the formation of Bandrowski base, which can block cellular oxidation mechanisms and cause anaphylaxis.3 Metabolites of PPD are excreted in the urine. Reports of PPD toxicity resulting from intent to self-harm via oral ingestion of PPD-containing hair dyes have been increasing in many countries such as Egypt, Morocco, Sudan, India, and Pakistan.4 Clinical presentation includes cola-coloured urine; decreased urine output; severe face, neck, or tongue edema causing respiratory impairment and occasionally necessitating tracheostomy; rhabdomyolysis; renal impairment; and elevated liver transaminase levels.4 The mortality rate after acute oral ingestion was 14.5% in a meta-analysis4 and 36% in a case series.3 Para-phenylenediamine is nondialyzable and management of toxicity is supportive, as no specific antidote is available.
Topical PPD exposure through hair dyes and henna tattoos can lead to sensitization and allergic contact dermatitis.6 Para-phenylenediamine is considered a top contact allergen by the American Contact Dermatitis Society,7 and median prevalence of positive PPD patch test results ranges from 4% to 6.2% in North America, Europe, and Asia.6 Of importance, dermatologic exposure may lead to systemic absorption and toxicity. In one study, persons who self-applied hair dyes excreted greater than 200 times more aromatic diamines than hairdressers did, possibly due to less consistent use of protective gloves and long-sleeved clothing,8 excessive scalp exposure, and prolonged contact time.6 Intermittent, repeated exposure to low-concentration PPD may lead to PPD accumulation over time.9
The first case of PPD toxicity in humans was published in 1924, with symptoms including tongue edema, nausea, and gastric pain in an otherwise healthy, middle-aged hairdresser. Hair dye used in his salon was found to contain PPD. The patient experienced no further symptoms after avoiding further dye exposure.10 Chronic renal failure with vasculitis and crescentic glomerulonephritis was reported in 2 women after long-term topical use of PPD-containing hair dye.11 Our patient experienced severe contact dermatitis and elevated liver enzyme levels 1 month after starting use of PPD-containing shampoo, with resolution of symptoms after discontinuation. We believe that our case is the first report of reversible drug-induced hepatitis secondary to use of hair dye shampoo containing PPD, but the prevalence may actually be higher due to lack of specific symptoms and underdiagnosis.
Para-phenylenediamine is a restricted ingredient on Health Canada’s Cosmetic Ingredient Hotlist, and hair dyes with PPD must display specific warnings and directions for safe use on the outer and inner product labels.12 Nevertheless, further consumer education regarding risks associated with PPD-containing products is important. Our patient continued to use PPD-containing shampoo despite experiencing contact dermatitis and did not report use of this shampoo until after repeated questioning by his physician during subsequent visits; by that time his liver enzyme levels had been elevated for 5 months. With increased awareness and more specific questioning, the cause of his hepatotoxicity could have been identified much earlier. Furthermore, as the population ages, use of hair-darkening products may increase. These products are often advertised as being “natural,” “organic,” “pure,” “ammonia-free,” or “herbal” to suggest safety or minimal risk.5,6 Patients are encouraged to check ingredient lists to identify PPD or other allergens. Many patients sensitized to PPD may be able to tolerate alternative permanent and semipermanent hair dyes, but there is a risk of cross-reactivity with other compounds that contain an amine group in their benzene ring.13 Wash in–wash out dyes are usually considered to be safe.6 Topical and systemic adverse reactions to PPD shampoo and other products should be reported to Health Canada’s postmarket surveillance program.14
Conclusion
Contact dermatitis frequently occurs with topical exposures to PPD-containing hair dyes, shampoos, and black henna. Prescribers should be aware that systemic absorption leading to serious toxicities, including hepatitis, may also occur after use of such products. Clinicians are encouraged to conduct a thorough medication history—including use of all prescription and over-the-counter medications, vitamins, herbal products, and complementary and alternative medicines, as well as exposure to cosmetic agents, dyes, and black henna tattoos—when investigating potential drug-related toxicities. Increasing consumer education and awareness regarding risks associated with use of PPD-containing products is recommended.
Notes
Editor’s key points
▸ Para-phenylenediamine (PPD) is commonly used in hair dyes and black henna products, and it may cause contact dermatitis; in some instances, topical exposure can lead to systemic toxicity.
▸ This is the first reported case of acute hepatitis induced by topical exposure to PPD-containing hair dye shampoo; the patient’s hepatitis was reversed upon discontinuation of shampoo use.
▸ Patients should be made aware of the risks of PPD-containing products and be advised to discontinue use immediately and to seek care if they experience severe dermatologic or systemic symptoms.
▸ When investigating potential drug-related hepatitis, clinicians are encouraged to conduct a thorough medication history and specifically inquire about the use of over-the-counter products and beauty supplies that may contain PPD. Adverse reactions to cosmetic products, drugs, or natural health products should be reported to Health Canada.
Points de repère du rédacteur
▸ La paraphénylènediamine (PPD) est communément utilisée dans les teintures capillaires et les produits de henné noir, et elle peut causer une dermatite de contact; dans certains cas, l’exposition topique peut entraîner une toxicité systémique.
▸ Il s’agit du premier cas signalé d’hépatite aiguë induite par une exposition topique à un shampoing colorant capillaire contenant de la PPD; l’hépatite du patient s’est résorbée lorsqu’il a cessé d’utiliser ce shampoing.
▸ Il faudrait informer les patients des risques que posent les produits contenant de la PPD, leur conseiller d’en cesser l’utilisation immédiatement et de consulter un médecin s’ils ressentent des symptômes dermatologiques ou systémiques graves.
▸ Dans les investigations entourant une hépatite potentiellement causée par des médicaments, les cliniciens sont encouragés à effectuer un bilan rigoureux des médicaments et à poser spécifiquement des questions sur l’utilisation de produits en vente libre et de produits de beauté qui pourraient contenir de la PPD. Les réactions indésirables aux produits cosmétiques, aux médicaments ou aux produits de santé naturels devraient être signalées à Santé Canada.
Footnotes
Competing interests
None declared
This article has been peer reviewed.
Cet article a fait l’objet d’une révision par des pairs.
- Copyright © 2023 the College of Family Physicians of Canada